Follow-up of Patients With FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukaemia in the Phase 3 ADMIRAL Trial

MLA

Perl, Alexander E., et al. Follow-up of Patients With FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukaemia in the Phase 3 ADMIRAL Trial. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....93d4da0c39c5a126ead667c77048f1aa&authtype=sso&custid=ns315887.

APA

Perl, A. E., Larson, R. A., Podoltsev, N. A., Strickland, S., Wang, E. S., Atallah, E., Schiller, G. J., Martinelli, G., Neubauer, A., Sierra, J., Montesinos, P., Recher, C., Yoon, S.-S., Hosono, N., Onozawa, M., Chiba, S., Kim, H.-J., Hasabou, N., Lu, Q., … Levis, M. J. (2022). Follow-up of Patients With FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukaemia in the Phase 3 ADMIRAL Trial.

Chicago

Perl, Alexander E., Richard A. Larson, Nikolai A. Podoltsev, Stephen Strickland, Eunice S. Wang, Ehab Atallah, Gary J. Schiller, et al. 2022. “Follow-up of Patients With FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukaemia in the Phase 3 ADMIRAL Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....93d4da0c39c5a126ead667c77048f1aa&authtype=sso&custid=ns315887.